Search for: "Takeda Pharmaceuticals" Results 1 - 20 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2024, 2:00 pm
Causation Experts Expert Opinion Testimony Medical Expert Survival and Wrongful Death Action General Causation – Specific Causation Exposure Necessary to Cause Specific Harm to Humans Motion in Limine California Law   Plaintiff Gary Garner appeals from a judgment entered against him after the trial court granted BNSF Railway Company’s (BNSF) motions in limine to exclude his causation experts, which resulted in the dismissal of his… [read post]
15 Feb 2024, 9:05 pm by Jordan Lassiter
Food and Drug Administration (FDA) approved Takeda Pharmaceutical’s therapy, Eohilia, for treating eosinophilic esophagitis—a chronic condition characterized by inflammation of the esophagus. [read post]
30 Jan 2024, 7:02 am by FRANK VINLUAN - MEDCITY NEWS
ArriVent BioPharma will apply the IPO cash toward furmonertinib, which the biotech says could offer advantages over Takeda Pharmaceutical and Johnson & Johnson drugs that address the same lung cancer target. [read post]
Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America, Inc.) sued to enjoin Defendants from marketing generic versions on the basis of inducing and/or contributorily infringing various patents, including U.S. [read post]
7 Dec 2023, 1:47 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
3 Oct 2023, 9:50 am by Seeger Weiss
Plaintiffs have yet to reach a settlement with Takeda Pharmaceuticals, the maker of PPI drugs Prevacid and Dexilant, and will continue to pursue claims against the company. [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Major pharmaceutical companies have set aside their differences to produce the Covid-19 vaccine. [read post]
17 Feb 2021, 9:09 pm by Patent Docs
Noonan -- In a terse, non-precedential opinion, the Federal Circuit affirmed a district court's judgment that Defendants Torrent Pharmaceuticals and Indoco Remedies Ltd. had failed to prove that the claims asserted by Plaintiff/patentee Takeda were obvious, either under the statute or the judicially created doctrine of obviousness-type double patenting, in Takeda Pharmaceutical Co. v. [read post]
29 Sep 2020, 5:52 am by MaxVal
The top assignees by the cumulative number of patent filings were Hoffmann-la Roche, AstraZeneca, Pfizer, Janssen Pharmaceuticals, Sanofi, GSK, Takeda, Vertex, Neurosearch, and Novartis. [read post]
1 Aug 2020, 7:52 am by Pete Strom
” This is the fourth guilty verdict levied against Takeda Pharmaceuticals for personal injury and wrongful death related to Actos use. [read post]
23 Jul 2020, 9:15 am by Jonathan Stroud
The District Court activity was driven by new complaints in existing campaigns, some new ANDA/aBLA litigations related to pharmaceutical generic entry, a smattering of company disputes, and a new... [read post]
23 Jul 2020, 9:15 am by Jonathan Stroud
The District Court activity was driven by new complaints in existing campaigns, some new ANDA/aBLA litigations related to pharmaceutical generic entry, a smattering of company disputes, and a new campaign by Raymond Anthony Joao. [read post]
13 Apr 2020, 5:46 am by Deb Givens
  Johnson & Johnson said on Friday it abandoned plans to buy Takeda Pharmaceutical’s surgical patch product TachoSil, citing regulatory issues. [read post]